NORTH AMERICA NASAL SPRAY MARKET 2021-2028

Lifesciences | Pharmaceuticals

NORTH AMERICA NASAL SPRAY MARKET 2021-2028

Market by Type, Prescription, Therapeutic, Application, End-user, and Country | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s report estimated that the nasal spray market in North America is expected to propel at a CAGR of 8.31% during the evaluated years 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries studied in this market are:

•        United States

•        Canada

As per the National Center for Chronic Disease Prevention and Health Promotion, a significant population suffers from obstructive pulmonary disease in the region. This has led to severe breathing problems. Here, breathing problems can also arise from lung cancer, tuberculosis, pneumonia, and other chronic conditions. Additionally, in the US, several people are diagnosed with hay fever or other allergies. This rise in conditions can be attributed to the surge in air pollution levels across the region. Hence, the growth in respiratory diseases supplements the development of the nasal spray market within North America.

In the United States, as per the Department of Health and Human Services, more than 25 million people have asthma, leading to high healthcare expenditure. Moreover, many people suffer from chronic obstructive pulmonary diseases, which cause breathing problems and other issues to arise. Further, lung disease has emerged as the third leading cause of death in the country. Other than this, allergic rhinitis and rhinosinusitis affect a significant amount of the population, resulting in nasal congestion. This further increases the need for nasal sprays.

Furthermore, there is a high prevalence of various conditions, including idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, and others, among the growing elderly population in the country. Hence, these factors are stimulating the adoption of nasal spray for various treatment applications, simultaneously boosting the nasal spray market on a growth path in the US.

Apotex Inc is a pharmaceutical company and is the largest producer of generic medicines. Its product line includes fluticasone propionate nasal spray that helps manage nasal systems of non-allergic rhinitis in adults and pediatric patients above the age of four. The company exports its products to over 100 countries. Besides, its divisions are focused on biosimilar development, generics, and the manufacturing of transdermal solutions. Apotex is headquartered in Toronto, Canada. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. NORTH AMERICA NASAL SPRAY MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON NASAL SPRAY MARKET

2.2. KEY INSIGHTS

2.2.1. ALLERGY TREATMENTS WITH NASAL SPRAYS

2.2.2. UTILIZING NASAL SPRAY FOR DIABETES

2.2.3. ENDOMETRIOSIS TREATMENT WITH NASAL SPRAYS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1. MERGERS & ACQUISITIONS

2.6.2. CONTRACTS & AGREEMENTS

2.6.3. DIVESTITURES

2.7. MARKET DRIVERS

2.7.1. EMERGING INTRANASAL VACCINES FOR COVID-19

2.7.2. INCREASING ACCEPTANCE OF SELF-ADMINISTRATION OF MEDICATION

2.7.3. GROWING USE OF NASAL SPRAYS DUE TO SIMPLE ADMINISTRATION TECHNIQUES

2.8. MARKET CHALLENGES

2.8.1. COMPLICATIONS DUE TO EXCESS USE OF NASAL SPRAYS

2.9. MARKET OPPORTUNITIES

2.9.1. APPLICATION OF NASAL SPRAYS IN TREATING DEPRESSION

2.9.2. USING INTRANASAL TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS

2.9.3. EMPLOYING NASAL SPRAY AS A VACCINE

3. NORTH AMERICA NASAL SPRAY MARKET OUTLOOK - BY TYPE

3.1. DECONGESTION NASAL SPRAY

3.2. STEROID NASAL SPRAY

3.3. SALTWATER SOLUTION/SALINE NASAL SPRAY

4. NORTH AMERICA NASAL SPRAY MARKET OUTLOOK - BY PRESCRIPTION

4.1. OVER-THE-COUNTER

4.2. PRESCRIBED

5. NORTH AMERICA NASAL SPRAY MARKET OUTLOOK - BY THERAPEUTIC

5.1. ANTIHISTAMINE

5.2. NASAL STEROIDS

5.3. ANTICHOLINERGIC

5.4. MAST CELL INHIBITOR

6. NORTH AMERICA NASAL SPRAY MARKET OUTLOOK - BY APPLICATION

6.1. NASAL CONGESTION

6.2. ALLERGIC AND NON-ALLERGIC RHINITIS

6.3. VACCINATION

6.4. CNS DISORDERS

6.5. OTHER APPLICATIONS

7. NORTH AMERICA NASAL SPRAY MARKET OUTLOOK - BY END-USER

7.1. HOME CARE SETTING

7.2. ASC/CLINICS

7.3. PHARMACY

7.4. HOSPITAL

7.5. OTHER END-USERS

8. NORTH AMERICA NASAL SPRAY MARKET – REGIONAL OUTLOOK

8.1. UNITED STATES

8.2. CANADA

9. COMPETITIVE LANDSCAPE

9.1. AKORN

9.2. ALLERGAN

9.3. APOTEX INC

9.4. BHARAT BIOTECH

9.5. CATALENT INC

9.6. CIPLA LIMITED

9.7. GLAXOSMITHKLINE

9.8. JOHNSON AND JOHNSON

9.9. NOVARTIS INTERNATIONAL AG

9.10. PFIZER INC

9.11. PROCTOR AND GAMBLE CO

9.12. SANOTIZE RESEARCH AND DEVELOPMENT

9.13. SUN PHARMACEUTICALS INDUSTRIES LTD

9.14. TEVA PHARMACEUTICAL INDUSTRIES LTD

9.15. VIATRIS

10. RESEARCH METHODOLOGY & SCOPE

10.1. RESEARCH SCOPE & DELIVERABLES

10.2. SOURCES OF DATA

10.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: NORTH AMERICA NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 4: NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)

TABLE 5: NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)

TABLE 6: NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: NORTH AMERICA NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 8: NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: NORTH AMERICA NASAL SPRAY MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 3: NORTH AMERICA NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 4: NORTH AMERICA NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 5: NORTH AMERICA NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 6: NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION, 2020 & 2028 (IN %)

FIGURE 7: NORTH AMERICA NASAL SPRAY MARKET, BY OVER-THE-COUNTER, 2021-2028 (IN $ MILLION)

FIGURE 8: NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC, 2020 & 2028 (IN %)

FIGURE 10: NORTH AMERICA NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)

FIGURE 11: NORTH AMERICA NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)

FIGURE 12: NORTH AMERICA NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 15: NORTH AMERICA NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)

FIGURE 16: NORTH AMERICA NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028 (IN $ MILLION)

FIGURE 17: NORTH AMERICA NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)

FIGURE 18: NORTH AMERICA NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 19: NORTH AMERICA NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 20: NORTH AMERICA NASAL SPRAY MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 21: NORTH AMERICA NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)

FIGURE 22: NORTH AMERICA NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 23: NORTH AMERICA NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)

FIGURE 24: NORTH AMERICA NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)

FIGURE 25: NORTH AMERICA NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 26: NORTH AMERICA NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 27: UNITED STATES NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 28: CANADA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying